SUNPHARMA's weekly performance was modest, with a return of 0.38%, outperforming its peers DRREDDY, DIVISLAB, and HINDUNILVR. Despite a relatively low volatility of 6.26%, the stock's Sharpe Ratio of 0.24 indicates a moderate risk-adjusted return. While the Max Drawdown of -0.47% suggests some downside risk, SUNPHARMA's overall performance was relatively stable compared to its peers.

[Volatility: 6.26%]